BIOMAT Database Logo BIOMAT Database Logo

Ganciclovir pharmacokinetics and suggested dosing in continuous venovenous haemodiafiltration. 2011

Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman

UI MeSH Term Description Entries
D008297 Male Males
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D006440 Hemofiltration Extracorporeal ULTRAFILTRATION technique without HEMODIALYSIS for treatment of fluid overload and electrolyte disturbances affecting renal, cardiac, or pulmonary function. Arteriovenous Hemofiltration,Venovenous Hemofiltration,Arteriovenous Hemofiltrations,Hemofiltration, Arteriovenous,Hemofiltration, Venovenous,Hemofiltrations,Venovenous Hemofiltrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592
D016638 Critical Illness A disease or state in which death is possible or imminent. Critically Ill,Critical Illnesses,Illness, Critical,Illnesses, Critical

Related Publications

Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration.
November 2007, The Journal of antimicrobial chemotherapy,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Doripenem population pharmacokinetics and dosing requirements for critically ill patients receiving continuous venovenous haemodiafiltration.
September 2014, The Journal of antimicrobial chemotherapy,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Anidulafungin dosing in critically ill patients with continuous venovenous haemodiafiltration.
June 2014, The Journal of antimicrobial chemotherapy,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Pharmacokinetics of moxifloxacin in patients undergoing continuous venovenous haemodiafiltration.
October 2004, The Journal of antimicrobial chemotherapy,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
April 2012, The Journal of antimicrobial chemotherapy,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
September 2004, British journal of clinical pharmacology,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Pharmacokinetics of ganciclovir in heart transplant patients undergoing continuous venovenous hemodialysis.
April 1993, Therapeutic drug monitoring,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients.
January 2014, Antimicrobial agents and chemotherapy,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Valproic acid overdose and continuous venovenous haemodiafiltration.
February 2008, NDT plus,
Steven McGloughlin, and Jason A Roberts, and Steven O'Donoghue, and Jennifer Martin, and Scott Briscoe, and Jeffrey Lipman
Gentamicin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration (CVVHDF).
March 2015, European journal of clinical pharmacology,
Copied contents to your clipboard!